Abstract
Glioblastoma multiforme (GBM) is the primary tumor of the central nervous system most frequently in adults, with an average survival of approximately 12 months. Multiple genetic and epigenetic alterations present in this tumor determine their biology and phenotype, quite aggressive. The standard treatment of GBM is a multidisciplinary approach involving neurosurgery, radiotherapy (RT) and…